Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Who Have Not Received Prior Treatment

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
The aim of this study is to evaluate the safety, tolerability, and pharmacokinetics of five ISIS 113715 intravenous dose cohorts in drug-naïve type 2 diabetics.
Epistemonikos ID: 11a78bb056b959519b0f39ceb68834a77af4c7b2
First added on: May 04, 2024